Hydroxyzine vs Benadryl for Itchy Rashes
Neither hydroxyzine nor diphenhydramine (Benadryl) is more effective than the other for treating itchy rashes—both are first-generation sedating antihistamines with similar efficacy, but modern guidelines recommend avoiding both as monotherapy in favor of non-sedating antihistamines due to safety concerns, particularly regarding sedation, reduced performance, and QT prolongation risk with hydroxyzine.
Current Guideline Recommendations
The most recent British Association of Dermatologists guidelines 1 explicitly recommend non-sedating antihistamines as first-line therapy for generalized pruritus, not sedating agents like hydroxyzine or diphenhydramine. For urticaria and itchy rashes, guidelines state that "the use of sedating antihistamines as monotherapy is now less common because of concerns about reduced concentration and performance" 2.
Key Clinical Considerations
Why Non-Sedating Antihistamines Are Preferred:
- Better safety profile: No impairment of concentration or performance
- Once-daily dosing: Better compliance (cetirizine, loratadine, fexofenadine)
- Equivalent or superior efficacy: Modern agents provide effective H1 receptor blockade without sedation
When Sedating Antihistamines May Be Used:
The guidelines suggest sedating antihistamines like hydroxyzine (10-50 mg) or chlorphenamine (4-12 mg) may be added at night only to a non-sedating antihistamine taken during the day 2. However, this combination "probably has little additional clinical effect on urticaria if the H1 receptor is already saturated" 2—the main benefit is helping patients sleep better, not improving the rash itself.
Important Safety Warnings for Hydroxyzine
Hydroxyzine carries specific risks that diphenhydramine does not:
- QT prolongation and Torsade de Pointes: Post-marketing reports show cardiac arrhythmia risk, especially in patients with heart disease, electrolyte imbalances, or taking other QT-prolonging drugs 3
- Contraindicated in pregnancy: Hydroxyzine is the only antihistamine specifically contraindicated in early pregnancy 2
- Acute Generalized Exanthematous Pustulosis (AGEP): Rare but serious skin reaction 3
- Avoid in elderly: Greater risk of confusion, over-sedation, and falls 3
- Avoid in severe liver disease: Sedating effect is inappropriate 2
Recommended Treatment Algorithm
- First-line: Start with a non-sedating H1 antihistamine (cetirizine, loratadine, or fexofenadine) once daily 1, 2
- If inadequate response: Increase the dose of the non-sedating antihistamine up to 4x the standard dose 2
- For sleep disruption only: Consider adding a sedating antihistamine at bedtime (but understand this won't significantly improve the rash itself)
- Adjunctive therapy: Emollients, topical cooling lotions (calamine, 1% menthol in aqueous cream) 1, 2
Common Pitfalls to Avoid
- Don't use hydroxyzine or diphenhydramine as monotherapy for daytime treatment—the sedation impairs quality of life without offering superior efficacy
- Don't assume sedating antihistamines work better—they don't; the sedation is a side effect, not a therapeutic benefit for the rash
- Screen for cardiac risk factors before prescribing hydroxyzine (personal/family history of long QT, recent MI, heart failure, concomitant QT-prolonging drugs) 3
- In elderly patients: Sedating antihistamines should be avoided entirely due to fall risk and confusion 1, 3
Bottom line: If you must choose between these two sedating antihistamines, diphenhydramine (Benadryl) has a longer safety track record and fewer cardiac concerns than hydroxyzine, but the correct answer is to use neither as primary therapy—prescribe a non-sedating antihistamine instead.